Your session is about to expire
← Back to Search
Personalized Dosing of Nicotine Patches for Nicotine Addiction
Study Summary
This trial will test if a higher dose of nicotine in patch form helps smokers quit when the standard dose fails.
- Tobacco Use Disorder
- Nicotine Addiction
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You smoke at least 10 cigarettes every day.You use tobacco products other than cigarettes regularly and are not willing to stop using them during the study.You have a skin condition that would make it difficult to use the patch.You have a serious heart condition or have had a heart attack or stroke within the past two weeks.You have a disease that cannot be cured and is in its final stages.You have taken any medication to quit smoking within the last two weeks.You use e-cigarettes or other vaping devices with nicotine regularly and are not willing to stop during the study.You plan to stop smoking in the next month.You are only willing to use tNRT (nicotine replacement therapy) to quit smoking and not other smoking cessation aids.
- Group 1: Placebo Condition
- Group 2: Experimental Condition
- Group 3: Quit condition
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are being admitted to this clinical trial?
"Correct. Clinicaltrials.gov confirms that this study is actively recruiting, with 500 participants needing to be enrolled from 1 medical centre. This trial was first posted on January 23rd 2018 and the most recent update occurred on August 23rd 2022."
Are there any openings for participation within this clinical experiment?
"Affirmative. Clinicaltrials.gov data suggests that recruitment for this trial is still ongoing, having first been posted on January 23rd 2018 and last updated on August 23rd 2022. The research team are seeking out 500 participants from 1 study site."
Has the FDA endorsed nicotine patch as a viable means of cessation?
"Due to the fact that this is a Phase 4 trial with an approved treatment, we at Power rate nicotine patch's safety as 3 on our scale."
Is it feasible for me to sign up for this clinical trial?
"This clinical trial is recruiting 500 people with tobacco addiction between the ages of 18 and 75. To be eligible, applicants must have a daily habit of 10 cigarettes or more, express an interest in tNRT as their primary smoking cessation aid, meet the age criteria listed above, and plan to quit within 30 days."
Has there been any previous research regarding the utilization of Nicotine Patch?
"As of the present moment, 71 clinical trials concerning Nicotine Patches are underway and 5 have progressed to Phase 3. Most studies are located in Green Bay, Wisconsin but 204 medical centres across the US offer this trial."
Is this trial accessible to adults aged eighteen and above?
"This medical trial is accepting applicants aged between 18 years and 75 years."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger